Abiopharma

(10% Negative) SILVERBACK THERAPEUTICS, INC. (SBTX) Announces Delay in anaphylaxis Trials for review ARS Pharmaceuticals Due to Pandemic-Related Challenges, Regulatory Process, Safety Review, Efficacy Assessment

(99% Neutral) Mereo BioPharma (MREO) Announces 2022 Annual General Meeting

(99% Neutral) Aurinia Pharmaceuticals Inc. (AUPH) Announces Executive Departure

(99% Neutral) HUTCHMED DRC (HCM) Files Form 6-K

Ironwood - Ironwood Pharmaceuticals Q3 2022 Investor Update Conference Call

Cytokinetics to Announce Third Quarter Results on November 3, 2022

(10% Negative) ChemoCentryx, Inc. (CCXI) Announces Delay in difference Development Timeline Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review

(10% Negative) AMGEN INC (AMGN) Announces Delay in difference Development Timeline Due to Pandemic-Related Challenges, Regulatory Process, Manufacturing Considerations, Safety Review

(90% Positive) Verastem, Inc. (VSTM) Announces Business Combination

(85% Positive) Larimar Therapeutics, Inc. (LRMR) Announces Enrollment Update for objectives Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment